Yvonne Pettigrew, diagnosed with primary progressive MS (PPMS) in 2013, shares her experience of living with PPMS and reacts to the "exciting" news that Ocrevus has been approved by NICE for NHS treatment of early, inflammatory PPMS.

Multiple sclerosis is a lifelong condition which affects the central nervous system (the brain and spinal cord). In primary progressive MS (PPMS), symptoms gradually worsen and accumulate over time, known as progression.

NICE has agreed that Mavenclad (cladribine) can be prescribed for active relapsing remitting MS, as an alternative to other highly effective disease modifying drugs.

Tecfidera (dimethyl fumarate) is a disease modifying drug treatment for relapsing remitting MS. You take Tecfidera as a pill twice a day.

The Yellow Card scheme is the way to report suspected side effects from medicines and suspected problems with all healthcare products.

What can we do to give ourselves the best chance of coping well with respiratory infection? Physiotherapist Jody Barber recommends taking the time now to expand your lungs, exercise your chest muscles and improve oxygen levels in your blood and brain. Sing, laugh, play the kazoo, stop smoking and breathe.

Hannah Morris-Bankole, researcher and PhD student at University of Reading, talks about psychological support in the early days following a diagnosis of MS. Multiple sclerosis and mental health issues. Newly diagnosed people may not know what they are entitled to and where to turn for help.

In his latest blog on MS and mental health, Will Berard writes candidly about the impact depression has had on him, and why we need to get better at recognising depression as a symptom of MS, and not just "because MS is a bummer. Man"

Fatigue is one of the most common and misunderstood MS symptoms. In this episode, we unpack what it really is, the emotional toll it can take, and practical ways to manage it, from pacing and planning to breaking the “boom and bust” cycle, with expert and lived experience.